McAleer C, Pointon A, Long C, Brighton R, Wilkin B, Bridges L, et al. On the potential of in vitro organ-chip models to define temporal pharmacokinetic-pharmacodynamic relationships. Sci Rep. 2019;9:9619 pubmed publisher

Segovia M, Russo S, Jeldres M, Mahmoud Y, Perez V, Duhalde M, et al. Targeting TMEM176B Enhances Antitumor Immunity and Augments the Efficacy of Immune Checkpoint Blockers by Unleashing Inflammasome Activation. Cancer Cell. 2019;35:767-781.e6 pubmed publisher

Liu J, Liu W, Lu Y, Tian H, Duan C, Lu L, et al. Piperlongumine restores the balance of autophagy and apoptosis by increasing BCL2 phosphorylation in rotenone-induced Parkinson disease models. Autophagy. 2018;14:845-861 pubmed publisher

Yamaoka T, Kitamura Y. Characterization of a highly sensitive and selective novel trapping reagent, stable isotope labeled glutathione ethyl ester, for the detection of reactive metabolites. J Pharmacol Toxicol Methods. 2015;76:83-95 pubmed publisher

Zeniou M, Fève M, Mameri S, Dong J, Salomé C, Chen W, et al. Chemical Library Screening and Structure-Function Relationship Studies Identify Bisacodyl as a Potent and Selective Cytotoxic Agent Towards Quiescent Human Glioblastoma Tumor Stem-Like Cells. PLoS ONE. 2015;10:e0134793 pubmed publisher

Guijarro Díez M, Nozal L, Marina M, Crego A. Metabolomic fingerprinting of saffron by LC/MS: novel authenticity markers. Anal Bioanal Chem. 2015;407:7197-213 pubmed publisher

Qu Y, Vargas H. Proarrhythmia Risk Assessment in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Using the Maestro MEA Platform. Toxicol Sci. 2015;147:286-95 pubmed publisher

Aits S, Kricker J, Liu B, Ellegaard A, Hämälistö S, Tvingsholm S, et al. Sensitive detection of lysosomal membrane permeabilization by lysosomal galectin puncta assay. Autophagy. 2015;11:1408-24 pubmed publisher

Lee E, Wu Z, Shon J, Liu K. Danazol Inhibits Cytochrome P450 2J2 Activity in a Substrate-independent Manner. Drug Metab Dispos. 2015;43:1250-3 pubmed publisher

Lee S, Kim M, Jung S, Lee S, Lee J. Altered plasma lysophosphatidylcholines and amides in non-obese and non-diabetic subjects with borderline-to-moderate hypertriglyceridemia: a case-control study. PLoS ONE. 2015;10:e0123306 pubmed publisher

Doherty K, TALBERT D, Trusk P, Moran D, Shell S, Bacus S. Structural and functional screening in human induced-pluripotent stem cell-derived cardiomyocytes accurately identifies cardiotoxicity of multiple drug types. Toxicol Appl Pharmacol. 2015;285:51-60 pubmed publisher

Xie S, Jia Y, Liu A, Dai R, Huang L. Hypaconitine-induced QT prolongation mediated through inhibition of KCNH2 (hERG) potassium channels in conscious dogs. J Ethnopharmacol. 2015;166:375-9 pubmed publisher

Kim M, Jung S, Lee S, Lee J. Association between arterial stiffness and serum L-octanoylcarnitine and lactosylceramide in overweight middle-aged subjects: 3-year follow-up study. PLoS ONE. 2015;10:e0119519 pubmed publisher

Boutin M, Auray Blais C. Metabolomic discovery of novel urinary galabiosylceramide analogs as Fabry disease biomarkers. J Am Soc Mass Spectrom. 2015;26:499-510 pubmed publisher

Yun J, Kim S. Antihistamines modulate the integrin signaling pathway in h9c2 rat cardiomyocytes: Possible association with cardiotoxicity. Hum Exp Toxicol. 2015;34:796-807 pubmed publisher

Tanaka H, Takahashi Y, Hamaguchi S, Iida Tanaka N, Oka T, Nishio M, et al. Effect of terfenadine and pentamidine on the HERG channel and its intracellular trafficking: combined analysis with automated voltage clamp and confocal microscopy. Biol Pharm Bull. 2014;37:1826-30 pubmed

Kim J, Do J, Choi J, Cho S, Kim W, Yoon C. Development and validation of an ultra-performance liquid chromatography method for simultaneous analysis of 20 antihistaminics in dietary supplements. Biomed Chromatogr. 2015;29:465-74 pubmed publisher

Hishinuma S, Sugawara K, Uesawa Y, Fukui H, Shoji M. Differential thermodynamic driving force of first- and second-generation antihistamines to determine their binding affinity for human H1 receptors. Biochem Pharmacol. 2014;91:231-41 pubmed publisher

Periat A, Kohler I, Bugey A, Bieri S, Versace F, Staub C, et al. Hydrophilic interaction chromatography versus reversed phase liquid chromatography coupled to mass spectrometry: effect of electrospray ionization source geometry on sensitivity. J Chromatogr A. 2014;1356:211-20 pubmed publisher

Kaspera R, Kirby B, Sahele T, Collier A, Kharasch E, Unadkat J, et al. Investigating the contribution of CYP2J2 to ritonavir metabolism in vitro and in vivo. Biochem Pharmacol. 2014;91:109-18 pubmed publisher

Kasutani K, Fujii E, Ohyama S, Adachi H, Hasegawa M, Kitamura H, et al. Anti-IL-31 receptor antibody is shown to be a potential therapeutic option for treating itch and dermatitis in mice. Br J Pharmacol. 2014;171:5049-58 pubmed publisher

Raveendran V, Kassel K, Smith D, Luyendyk J, Williams K, Cherian R, et al. H1-antihistamines exacerbate high-fat diet-induced hepatic steatosis in wild-type but not in apolipoprotein E knockout mice. Am J Physiol Gastrointest Liver Physiol. 2014;307:G219-28 pubmed publisher

Pajula K, Wittoek L, Lehto V, Ketolainen J, Korhonen O. Phase separation in coamorphous systems: in silico prediction and the experimental challenge of detection. Mol Pharm. 2014;11:2271-9 pubmed publisher

Vasa D, Dalal N, Katz J, Roopwani R, Nevrekar A, Patel H, et al. Physical characterization of drug:polymer dispersion behavior in polyethylene glycol 4000 solid dispersions using a suite of complementary analytical techniques. J Pharm Sci. 2014;103:2911-2923 pubmed publisher

Lee B, Wu Z, Sung S, Lee T, Song K, Lee M, et al. Potential of decursin to inhibit the human cytochrome P450 2J2 isoform. Food Chem Toxicol. 2014;70:94-9 pubmed publisher

Guzman Y. You're the flight surgeon: nasal congestion and Eustachian tube dysfunction. Aviat Space Environ Med. 2013;84:268-9 pubmed

Chaudhari G, Chennubhotla K, Chatti K, Kulkarni P. Optimization of the adult zebrafish ECG method for assessment of drug-induced QTc prolongation. J Pharmacol Toxicol Methods. 2013;67:115-20 pubmed publisher

Shirasaka Y, Shichiri M, Murata Y, Mori T, Nakanishi T, Tamai I. Long-lasting inhibitory effect of apple and orange juices, but not grapefruit juice, on OATP2B1-mediated drug absorption. Drug Metab Dispos. 2013;41:615-21 pubmed publisher

Togami K, Tosaki Y, Chono S, Morimoto K, Hayasaka M, Tada H. Enantioselective uptake of fexofenadine by Caco-2 cells as model intestinal epithelial cells. J Pharm Pharmacol. 2013;65:22-9 pubmed publisher

Kusuhara H, Miura M, Yasui Furukori N, Yoshida K, Akamine Y, Yokochi M, et al. Effect of coadministration of single and multiple doses of rifampicin on the pharmacokinetics of fexofenadine enantiomers in healthy subjects. Drug Metab Dispos. 2013;41:206-13 pubmed publisher

Dhaneshwar S, Gautam H. Exploring novel colon-targeting antihistaminic prodrug for colitis. J Physiol Pharmacol. 2012;63:327-37 pubmed

Covell D. Integrating constitutive gene expression and chemoactivity: mining the NCI60 anticancer screen. PLoS ONE. 2012;7:e44631 pubmed publisher

Jacobs A, Didone L, Jobson J, Sofia M, KRYSAN D, Dunman P. Adenylate kinase release as a high-throughput-screening-compatible reporter of bacterial lysis for identification of antibacterial agents. Antimicrob Agents Chemother. 2013;57:26-36 pubmed publisher

Yamamoto H, Yonekura S, Sakurai D, Katada K, Inamine A, Hanazawa T, et al. Comparison of nasal steroid with antihistamine in prophylactic treatment against pollinosis using an environmental challenge chamber. Allergy Asthma Proc. 2012;33:397-403 pubmed publisher

Church M, Maurer M. H(1)-antihistamines and urticaria: how can we predict the best drug for our patient?. Clin Exp Allergy. 2012;42:1423-9 pubmed publisher

Caster O, Norén G, Ekenberg L, Edwards I. Quantitative benefit-risk assessment using only qualitative information on utilities. Med Decis Making. 2012;32:E1-15 pubmed publisher

Barrett O Keefe Z, Kaplon R, Halliwill J. Sustained postexercise vasodilatation and histamine receptor activation following small muscle-mass exercise in humans. Exp Physiol. 2013;98:268-77 pubmed publisher

Nogaki T, Asano K, Furuta A, Kanai K, Suzaki I, Kanei A, et al. Enhancement of clara cell 10-kD protein (CC10) production from nasal epithelial cells by fexofenadine hydrochloride. Asian Pac J Allergy Immunol. 2012;30:139-45 pubmed

Tanaka Y, Yoshikawa Y, Yasui H. Development of a highly sensitive methodology for quantitative determination of fexofenadine in a microdose study by multiple injection method using ultra-high performance liquid chromatography with tandem mass spectrometry. Biol Pharm Bull. 2012;35:698-704 pubmed

Yamada K, Takizawa F, Tamura T, Kanda T. The effect of antihistamines on seizures induced by increasing-current electroshocks: ketotifen, but not olopatadine, promotes the seizures in infant rats. Biol Pharm Bull. 2012;35:693-7 pubmed

Ohura K, Soejima T, Nogata R, Adachi Y, Ninomiya S, Imai T. Effect of intestinal first-pass hydrolysis on the oral bioavailability of an ester prodrug of fexofenadine. J Pharm Sci. 2012;101:3264-74 pubmed publisher

Nguemo F, Saric T, Pfannkuche K, Watzele M, Reppel M, Hescheler J. In vitro model for assessing arrhythmogenic properties of drugs based on high-resolution impedance measurements. Cell Physiol Biochem. 2012;29:819-32 pubmed publisher

Suzuki K, Shitara Y, Fukuda K, Horie T. Long-lasting inhibition of the intestinal absorption of fexofenadine by cyclosporin A in rats. J Pharm Sci. 2012;101:2606-15 pubmed publisher

Mathias S, Tschosik E, Zazzali J. Adaptation and validation of the Urticaria Patient Daily Diary for adolescents. Allergy Asthma Proc. 2012;33:186-90 pubmed publisher

Qiang F, Shin H, Lee B, Han H. Enhanced systemic exposure of fexofenadine via the intranasal administration of chitosan-coated liposome. Int J Pharm. 2012;430:161-6 pubmed publisher

Andoh T, Sakai K, Urashima M, Kitazawa K, Honma A, Kuraishi Y. Involvement of leukotriene B4 in itching in a mouse model of ocular allergy. Exp Eye Res. 2012;98:97-103 pubmed publisher

Fujii M, Ohya S, Yamamura H, Imaizumi Y. Development of recombinant cell line co-expressing mutated Nav1.5, Kir2.1, and hERG for the safety assay of drug candidates. J Biomol Screen. 2012;17:773-84 pubmed publisher

Ali S, Khan S, Crowyn G. Structure determination of fexofenadine-α-cyclodextrin complex by quantitative 2D ROESY analysis and molecular mechanics studies. Magn Reson Chem. 2012;50:299-304 pubmed publisher

Liu X, Limberis J, Su Z, Houseman K, Diaz G, Gintant G, et al. Characterization of A-935142, a hERG enhancer, in the presence and absence of standard hERG blockers. Life Sci. 2012;90:607-11 pubmed publisher

Saruwatari J, Yasui Furukori N, Niioka T, Akamine Y, Takashima A, Kaneko S, et al. Different effects of the selective serotonin reuptake inhibitors fluvoxamine, paroxetine, and sertraline on the pharmacokinetics of fexofenadine in healthy volunteers. J Clin Psychopharmacol. 2012;32:195-9 pubmed publisher

Liu Z, Shi Q, Ding D, Kelly R, Fang H, Tong W. Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). PLoS Comput Biol. 2011;7:e1002310 pubmed publisher

Wlodarczyk N, Le Broc Ryckewaert D, Gilleron P, Lemoine A, Farce A, Chavatte P, et al. Potent farnesyltransferase inhibitors with 1,4-diazepane scaffolds as novel destabilizing microtubule agents in hormone-resistant prostate cancer. J Med Chem. 2011;54:1178-90 pubmed publisher

Sinha N, Sen S. Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model. Eur J Med Chem. 2011;46:618-30 pubmed publisher

Schmalhofer W, Swensen A, Thomas B, Felix J, Haedo R, Solly K, et al. A pharmacologically validated, high-capacity, functional thallium flux assay for the human Ether-à-go-go related gene potassium channel. Assay Drug Dev Technol. 2010;8:714-26 pubmed publisher

Ekins S, Williams A, Xu J. A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug Metab Dispos. 2010;38:2302-8 pubmed publisher

Soulère L, Sabbah M, Fontaine F, Queneau Y, Doutheau A. LuxR-dependent quorum sensing: computer aided discovery of new inhibitors structurally unrelated to N-acylhomoserine lactones. Bioorg Med Chem Lett. 2010;20:4355-8 pubmed publisher

Greene N, Fisk L, Naven R, Note R, Patel M, Pelletier D. Developing structure-activity relationships for the prediction of hepatotoxicity. Chem Res Toxicol. 2010;23:1215-22 pubmed publisher

Prado Prado F, Garcia Mera X, González Díaz H. Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorg Med Chem. 2010;18:2225-2231 pubmed publisher

Abu Khalaf R, Abu Sheikha G, Bustanji Y, Taha M. Discovery of new cholesteryl ester transfer protein inhibitors via ligand-based pharmacophore modeling and QSAR analysis followed by synthetic exploration. Eur J Med Chem. 2010;45:1598-617 pubmed publisher

Fourches D, Barnes J, Day N, Bradley P, Reed J, Tropsha A. Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chem Res Toxicol. 2010;23:171-83 pubmed publisher

Lee P, Conradi R, Shanmugasundaram V. Development of an in silico model for human skin permeation based on a Franz cell skin permeability assay. Bioorg Med Chem Lett. 2010;20:69-73 pubmed publisher

Yuan J, Johnson R, Huang R, Wichterman J, Jiang H, Hayton K, et al. Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum. Nat Chem Biol. 2009;5:765-71 pubmed publisher

Aslanian R, Piwinski J, Zhu X, Priestley T, Sorota S, Du X, et al. Structural determinants for histamine H(1) affinity, hERG affinity and QTc prolongation in a series of terfenadine analogs. Bioorg Med Chem Lett. 2009;19:5043-7 pubmed publisher

Zachariae U, Giordanetto F, Leach A. Side chain flexibilities in the human ether-a-go-go related gene potassium channel (hERG) together with matched-pair binding studies suggest a new binding mode for channel blockers. J Med Chem. 2009;52:4266-76 pubmed publisher

Imai Y, Ryu S, Oiki S. Docking model of drug binding to the human ether-à-go-go potassium channel guided by tandem dimer mutant patch-clamp data: a synergic approach. J Med Chem. 2009;52:1630-8 pubmed publisher

Ermondi G, Visentin S, Caron G. GRIND-based 3D-QSAR and CoMFA to investigate topics dominated by hydrophobic interactions: the case of hERG K+ channel blockers. Eur J Med Chem. 2009;44:1926-32 pubmed publisher

Ahlin G, Karlsson J, Pedersen J, Gustavsson L, Larsson R, Matsson P, et al. Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. J Med Chem. 2008;51:5932-42 pubmed publisher

Pedersen J, Matsson P, Bergström C, Norinder U, Hoogstraate J, Artursson P. Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2). J Med Chem. 2008;51:3275-87 pubmed publisher

Jia L, Sun H. Support vector machines classification of hERG liabilities based on atom types. Bioorg Med Chem. 2008;16:6252-60 pubmed publisher

Kornhuber J, Tripal P, Reichel M, Terfloth L, Bleich S, Wiltfang J, et al. Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model. J Med Chem. 2008;51:219-37 pubmed

Bergström C, Wassvik C, Johansson K, Hubatsch I. Poorly soluble marketed drugs display solvation limited solubility. J Med Chem. 2007;50:5858-62 pubmed

Chen C. Some pharmacokinetic aspects of the lipophilic terfenadine and zwitterionic fexofenadine in humans. Drugs R D. 2007;8:301-14 pubmed

Diamandis P, Wildenhain J, Clarke I, Sacher A, Graham J, Bellows D, et al. Chemical genetics reveals a complex functional ground state of neural stem cells. Nat Chem Biol. 2007;3:268-73 pubmed

Zhu B, Jia Z, Zhang P, Su T, Huang W, Goldman E, et al. Inhibitory effect of carboxylic acid group on hERG binding. Bioorg Med Chem Lett. 2006;16:5507-12 pubmed

MacDonald M, Lamerdin J, Owens S, Keon B, Bilter G, Shang Z, et al. Identifying off-target effects and hidden phenotypes of drugs in human cells. Nat Chem Biol. 2006;2:329-37 pubmed

Bondebjerg J, Fuglsang H, Valeur K, Pedersen J, Naerum L. Dipeptidyl nitriles as human dipeptidyl peptidase I inhibitors. Bioorg Med Chem Lett. 2006;16:3614-7 pubmed

Lafite P, Dijols S, Buisson D, Macherey A, Zeldin D, Dansette P, et al. Design and synthesis of selective, high-affinity inhibitors of human cytochrome P450 2J2. Bioorg Med Chem Lett. 2006;16:2777-80 pubmed

Rufke C, Nieber K. [Long QT interval. Interaction of terfenadine and itraconazole]. Med Monatsschr Pharm. 2006;29:22-4 pubmed

Wang Y, Li Y, Li Y, Yang S, Yang L. Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism. Bioorg Med Chem Lett. 2005;15:4076-84 pubmed

Tobita M, Nishikawa T, Nagashima R. A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors. Bioorg Med Chem Lett. 2005;15:2886-90 pubmed

Caron G, Ermondi G. Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk). J Med Chem. 2005;48:3269-79 pubmed

Cianchetta G, Singleton R, Zhang M, Wildgoose M, Giesing D, Fravolini A, et al. A pharmacophore hypothesis for P-glycoprotein substrate recognition using GRIND-based 3D-QSAR. J Med Chem. 2005;48:2927-35 pubmed

Zhang H, Derian C, McComsey D, White K, Ye H, Hecker L, et al. Novel indolylindazolylmaleimides as inhibitors of protein kinase C-beta: synthesis, biological activity, and cardiovascular safety. J Med Chem. 2005;48:1725-8 pubmed

Rajamani R, Tounge B, Li J, Reynolds C. A two-state homology model of the hERG K+ channel: application to ligand binding. Bioorg Med Chem Lett. 2005;15:1737-41 pubmed

Inagaki N, Igeta K, Kim J, Nagao M, Shiraishi N, Nakamura N, et al. Involvement of unique mechanisms in the induction of scratching behavior in BALB/c mice by compound 48/80. Eur J Pharmacol. 2002;448:175-83 pubmed

Luk H, Ko J, Fung H, Cho C. Delineation of the protective action of zinc sulfate on ulcerative colitis in rats. Eur J Pharmacol. 2002;443:197-204 pubmed

Ohtani H, Hanada E, Hirota M, Sato H, Kotaki H, Sawada Y, et al. Inhibitory effects of the antihistamines epinastine, terfenadine, and ebastine on potassium currents in rat ventricular myocytes. J Pharm Pharmacol. 1999;51:1059-63 pubmed

Taglialatela M, Castaldo P, Pannaccione A, Giorgio G, Genovese A, Marone G, et al. Cardiac ion channels and antihistamines: possible mechanisms of cardiotoxicity. Clin Exp Allergy. 1999;29 Suppl 3:182-9 pubmed

van den Anker J, de Wildt S. [Excessive terfenadine level due to drinking grapefruit juice]. Ned Tijdschr Geneeskd. 1997;141:1976-8 pubmed

Endre L, Mezei G, Kosa L, Börzsönyi L, Cserhati E. [Multicenter studies of terfenadine-containing suspensions in children with hayfever]. Orv Hetil. 1998;139:11-5 pubmed

Ishizaki T. Strategic proposals to avoid drug interactions during drug development: a lesson from a terfenadine-related drug interaction. J Toxicol Sci. 1996;21:301-3 pubmed

Aaronson D. Effects of terfenadine on psychomotor performance. An overview. Drug Saf. 1993;8:321-9 pubmed

Jankowski R, Wagenmann M, Baroody F, Naclerio R. Effect of terfenadine on nasal provocation. Int Arch Allergy Immunol. 1993;101:311-7 pubmed

Masheter H. Terfenadine. The first nonsedating antihistamine. Clin Rev Allergy. 1993;11:5-34 pubmed

Zhang M, Timmerman H. Terfenadine: a mixture of equipotent antihistamine enantiomers without a clear 'isomeric ballast'. Pharm World Sci. 1993;15:186-92 pubmed

Pohjola Sintonen S. [Treatment with terfenadine and ketoconazole or itraconazole can cause torsades de pointes ventricular tachycardia]. Duodecim. 1993;109:164-6 pubmed

Kivistö K, Neuvonen P, Klotz U. Inhibition of terfenadine metabolism. Pharmacokinetic and pharmacodynamic consequences. Clin Pharmacokinet. 1994;27:1-5 pubmed

Paris D, Parente T, Bruschetta H, Guzman E, Niarchos A. Torsades de pointes induced by erythromycin and terfenadine. Am J Emerg Med. 1994;12:636-8 pubmed

Wynn R. Erythromycin and ketoconazole (Nizoral) associated with terfenadine (Seldane)-induced ventricular arrhythmias. Gen Dent. 1993;41:27-9 pubmed

Carter C, Wojciechowski N, Hayes J, Skoutakis V, Rickman L. Terfenadine, a nonsedating antihistamine. Drug Intell Clin Pharm. 1985;19:812-7 pubmed

Sorkin E, Heel R. Terfenadine. A review of its pharmacodynamic properties and therapeutic efficacy. Drugs. 1985;29:34-56 pubmed

Brooks C, Karl K, Francom S. Profile of ragweed hay fever symptom control with terfenadine started before or after symptoms are established. Clin Exp Allergy. 1990;20:21-6 pubmed

McTavish D, Goa K, Ferrill M. Terfenadine. An updated review of its pharmacological properties and therapeutic efficacy. Drugs. 1990;39:552-74 pubmed

Ciprandi G, Iudice A, Tosca M, Ruffoni S, Buscaglia S, Canonica G. Comparative effects of terfenadine and loratadine in the treatment of hay fever. J Investig Allergol Clin Immunol. 1991;1:368-72 pubmed

Cortese L, Bjornson D. Comment: the new macrolide antibiotics and terfenadine. Ann Pharmacother. 1992;26:1019 pubmed